Regeneron Pharmaceuticals, Inc.
REGN
$768.29
$1.630.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.61B | 8.44B | 7.47B | 8.35B | 9.01B |
| Total Receivables | 5.74B | 5.69B | 5.61B | 5.56B | 6.21B |
| Inventory | 3.20B | 3.25B | 3.21B | 3.19B | 3.09B |
| Prepaid Expenses | 469.20M | 588.90M | 554.50M | 466.10M | 348.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.60M | 6.70M | 19.80M | 2.80M | 800.00K |
| Total Current Assets | 18.02B | 17.98B | 16.86B | 17.57B | 18.66B |
|
|
|||||
| Total Current Assets | 18.02B | 17.98B | 16.86B | 17.57B | 18.66B |
| Net Property, Plant & Equipment | 5.37B | 5.00B | 4.84B | 4.69B | 4.82B |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.26B | 1.38B | 1.35B | 1.17B | 1.15B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.32B | 5.10B | 4.70B | 4.45B | 4.07B |
| Total Assets | 40.56B | 40.17B | 38.22B | 37.55B | 37.76B |
|
|
|||||
| Total Accounts Payable | 939.00M | 903.80M | 723.90M | 705.50M | 789.50M |
| Total Accrued Expenses | 2.36B | 2.98B | 2.46B | 2.24B | 1.96B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 519.30M | -- | -- | -- | 571.10M |
| Total Finance Division Other Current Liabilities | 553.00M | 545.60M | 481.90M | 619.30M | 627.70M |
| Total Other Current Liabilities | 553.00M | 545.60M | 481.90M | 619.30M | 627.70M |
| Total Current Liabilities | 4.37B | 4.43B | 3.67B | 3.57B | 3.94B |
|
|
|||||
| Total Current Liabilities | 4.37B | 4.43B | 3.67B | 3.57B | 3.94B |
| Long-Term Debt | 1.99B | 1.99B | 1.99B | 1.98B | 1.98B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 949.00M | 720.00M | 720.00M | 720.00M | 924.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.00B | 2.08B | 1.91B | 1.89B | 1.55B |
| Total Liabilities | 9.30B | 9.21B | 8.28B | 8.16B | 8.41B |
|
|
|||||
| Common Stock & APIC | 14.00B | 13.79B | 13.49B | 13.19B | 12.86B |
| Retained Earnings | 35.80B | 35.05B | 33.68B | 32.38B | 31.67B |
| Treasury Stock & Other | -18.54B | -17.88B | -17.23B | -16.19B | -15.18B |
| Total Common Equity | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B |
|
|
|||||